Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
QuintilesIMS
Fuji
Cantor Fitzgerald
Express Scripts
Federal Trade Commission
Citi
Teva
Cerilliant

Generated: April 22, 2018

DrugPatentWatch Database Preview

RASAGILINE MESYLATE Drug Profile

« Back to Dashboard

Which patents cover Rasagiline Mesylate, and what generic alternatives are available?

Rasagiline Mesylate is a drug marketed by Alkem Labs Ltd, Apotex Inc, Mylan Pharms Inc, Orchid Hlthcare, and Watson Labs Inc. and is included in five NDAs.

The generic ingredient in RASAGILINE MESYLATE is rasagiline mesylate. There are eighteen drug master file entries for this compound. Seven suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the rasagiline mesylate profile page.
Drug patent expirations by year for RASAGILINE MESYLATE
Pharmacology for RASAGILINE MESYLATE
Synonyms for RASAGILINE MESYLATE
(+)-AGN-1135
(1R)-2,3-Dihydro-N-2-propyn-1-yl-1H-inden-1-amine Mesylate
(1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate
(1R)-N-(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine; methanesulfonic acid
(R)-2,3-Dihydro-N-2-propynyl-1-indenamine Mesylate
(R)-N-(Prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine methanesulfonate
(R)-N-2-Propynyl-1-indanamine methanesulfonate
161735-79-1
1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (1R)-, methanesulfonate
1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (R)-, methanesulfonate
735R791
AB0011313
AB2000506
AC-724
AC1MHJZQ
ACT06733
Agilect
AK-60119
AKOS005145768
AN-6874
ANW-52542
AX8150251
Azilect
BC213842
BG0559
BS-1009
CAS-161735-79-1
CC-34228
CHEMBL1201142
CS-2458
CTK8B6102
D02562
DSSTox_CID_27826
DSSTox_GSID_47848
DSSTox_RID_82589
DTXSID8047848
EN300-123038
FT-0631191
HY-14605
I09-0543
JDBJJCWRXSVHOQ-UTONKHPSSA-N
KB-81371
KS-00000H13
LH8C2JI290
LS-186552
MCULE-3183761977
methanesulfonic acid; (1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine
methanesulfonic acid; (1R)-N-prop-2-ynylindan-1-amine
methanesulfonic acid;(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine
MFCD08460604
MolPort-005-937-324
N-Propargyl-1(R)-aminoindan methanesulfonate
NCGC00168774-01
NCGC00168774-02
OR227636
Q-101873
Rasagiline (mesylate)
Rasagiline mesilate
Rasagiline mesilate (JAN)
Rasagiline mesylate (USAN)
Rasagiline mesylate [USAN]
Rasagiline mesylate, >=98% (HPLC)
Rasagiline methanesulfonate
RL02071
s2102
SBB062837
SC-08804
SCHEMBL158439
ST24049117
TC-064138
Tox21_112635
Tox21_112635_1
TV 1012
TV-1030
TVP 1012
TVP-1012
UNII-LH8C2JI290
Z1820079046

US Patents and Regulatory Information for RASAGILINE MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 201889-001 Oct 30, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Orchid Hlthcare RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 201970-001 Mar 15, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex Inc RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 201950-002 Sep 12, 2013 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Orchid Hlthcare RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 201970-002 Mar 15, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
AstraZeneca
Merck
Daiichi Sankyo
Covington
Teva
US Department of Justice
Boehringer Ingelheim
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.